Topical imiquimod as first-line treatment for vulvar intraepithelial neoplasia.

Voss, Féline O; van Beurden, Marc; Jordanova, Ekaterina S

Voss, Féline O; van Beurden, Marc; Jordanova, Ekaterina S.

Afiliação

Voss FO; Centre for Gynaecological Oncology Amsterdam, Netherlands Cancer Institute, Antoni Van Leeuwenhoek Hospital, Amsterdam, Netherlands; Department of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands Universiteit Amsterdam, Amsterdam, Netherlands; Imaging and Biomarkers, Cancer Centre Amsterdam, Amsterdam, Netherlands.
van Beurden M; Centre for Gynaecological Oncology Amsterdam, Netherlands Cancer Institute, Antoni Van Leeuwenhoek Hospital, Amsterdam, Netherlands.
Jordanova ES; Department of Urology, Netherlands Cancer Institute, Antoni Van Leeuwenhoek Hospital, Amsterdam, Netherlands; Department of Obstetrics and Gynecology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands Universiteit Amsterdam, Amsterdam, Netherlands. Electronic address: e.jordanova@amsterdamumc.nl.

Lancet ; 399(10337): 1755-1757, 2022 05 07.

Article em En | MEDLINE | ID: mdl-35483402

Assuntos

Antineoplásicos; Carcinoma in Situ; Neoplasias Vulvares; Administração Tópica; Aminoquinolinas/uso terapêutico; Antineoplásicos/uso terapêutico; Carcinoma in Situ/tratamento farmacológico; Feminino; Humanos; Imiquimode/uso terapêutico; Neoplasias Vulvares/tratamento farmacológico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias Vulvares / Carcinoma in Situ / Antineoplásicos Limite: Female / Humans Idioma: En Revista: Lancet Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google